Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · IEX Real-Time Price · USD
0.937
-0.023 (-2.42%)
At close: Jul 19, 2024, 4:00 PM
0.940
+0.003 (0.34%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Compass Therapeutics Stock Forecast
CMPX's stock price has decreased by -65.04% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CMPX stock has a target of 10, which predicts an increase of 967.46% from the current stock price of 0.94.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 3, 2024.
Analyst Ratings
The average analyst rating for CMPX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +967.46% | Jun 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +967.46% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +967.46% | May 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +967.46% | Apr 16, 2024 |
| Wedbush | Wedbush | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Mar 22, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
6.34M
EPS This Year
-0.40
from -0.33
EPS Next Year
-0.46
from -0.40
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 26.3M | 157.2M | 389.5M | 644.4M |
| Avg | n/a | 6.3M | 80.0M | 198.1M | 345.0M |
| Low | n/a | n/a | 37.9M | 83.6M | 154.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 2,378.6% | 386.9% | 225.4% |
| Avg | - | - | 1,161.5% | 147.6% | 74.2% |
| Low | - | - | 498.1% | 4.5% | -22.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.38 | -0.27 | 0.29 | 1.32 | 2.08 |
| Avg | -0.40 | -0.46 | -0.25 | 0.20 | 0.80 |
| Low | -0.42 | -0.67 | -0.58 | -0.33 | 0.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 929.4% |
| Avg | - | - | - | - | 298.0% |
| Low | - | - | - | - | -27.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.